Ph.D., Vice Chancellor Research, Executive Vice Dean Medicine School and Professor of Cellular and Molecular Pharmacology UCSF
Keith Yamamoto, PhD, is Vice Chancellor of Research, Executive Vice Dean and Professor of Cellular and Molecular Pharmacology at the UCSF School of Medicine. He oversees strategic planning and all research activities. Dr. Yamamoto’s research focuses on nuclear receptors. He identified the glucocorticoid response elements, the genomic sequences to which the glucocorticoid receptor binds in order to control gene transcription.
Known as an international leader for his involvement in science policy, he serves as Chairman of the Board on Life Sciences at the National Academy of Sciences, as well as numerous government and public advisory boards, including the NIH Center for Scientific Review Advisory Council. He earned his PhD at Princeton, and arrived at UCSF in 1973.
Precision Medicine: Beyond The Inflection Point
We are currently observing a dramatic acceleration and transformation of biomedicine, particularly when compared to a previously more steady and incremental progress. This change in accelerated progress is due precision medicine driven by the confluence of biological, physical, engineering, computer, and health sciences which is setting the stage for a transformative leap toward data-driven, mechanism-based health and health care for each individual.